Aldesleukin Terminated Phase 1 Trials for Colorectal Cancers / Malignant Neoplasm of Stomach / Unspecified Adult Solid Tumor, Protocol Specific / Lung Cancers / Breast Cancer / Malignant Neoplasm of Pancreas / Ovarian Cancer Treatment

TerminatedTreatment1 IdentifierTitleDrugs
NCT02070406Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
NCT00003009Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
NCT01212887Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
NCT00569296Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer